Doctors at KIMS Hospitals, Kondapur, have performed a rare and highly complex laparoscopic Whipple procedure on a 52-year-old woman who had previously undergone open pancreatic surgery, marking a ...

"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as ...

A virus has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially ...

Luisa Escobar-Hoyos envisions a world where a pancreatic cancer diagnosis is no longer a death sentence. “Every time I tell people I work on pancreatic cancer, people are like, ‘That’s a really bad ...

A new drug for pancreatic cancer is showing promise in early testing. Daraxonrasib is a daily pill designed to block cancer signals linked to the RAS gene. It has now finished an early-stage clinical ...

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a drug that ...

“Pancreatic cancer is often called a silent disease because it rarely causes noticeable symptoms in its early stages. By the time patients recognize there is a problem, it has usually progressed to ...

The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it. The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.

The drug's benefits significantly outweigh its adverse effects, researchers say Survival time is roughly doubled with daraxonrasib vs standard chemotherapy Drug targets a mutation found in 90% of ...